Frequency of Diabetic Nephropathy among Patients of Type 2 Diabetes Mellitus
Diabetic Nephropathy among Type 2 Diabetes Mellitus
DOI:
https://doi.org/10.54393/pjhs.v6i5.2896Keywords:
Diabetic Nephropathy, Type 2 Diabetes Mellitus, Glycemic Control, MicroalbuminuriaAbstract
Diabetic Nephropathy (DN) is a predominant consequence of Type 2 Diabetes Mellitus (T2DM), contributing to chronic renal disease. Objective: To determine the frequency of diabetic nephropathy and its correlation with glycemic control. Methods: A cross-sectional study was conducted at the Nephrology and Diabetic OPD of Lahore General Hospital from July to November 2024. A total of 282 type 2 diabetic patients were enrolled. Clinical evaluation, fundoscopy, neurological examination, and laboratory tests were performed. Diabetic nephropathy was diagnosed based on albuminuria and eGFR. Statistical significance was set at p < 0.05. Results: Out of 282 patients, 150 (53.2%) were males and 132 (46.8%) females. The majority (43.3%) were aged 50–59 years. Microalbuminuria and macroalbuminuria were present in 20.9% and 32.3%, respectively. Mean serum creatinine and eGFR were 1.16 ± 0.53 mg/dL and 68.15 ± 24.58 mL/min/1.73m². Mean HbA1c and FBS levels were 8.40 ± 1.84% and 137.03 ± 19.19 mg/dL. Hypertension was noted in 41.5%. Diabetic nephropathy was significantly more prevalent in those with FBS >140 mg/dL (29.1%) and HbA1c >7.5% (32.6%) compared to those with lower values (p < 0.05). Declining eGFR was also significantly associated with nephropathy, with most cases found in those with eGFR <60 mL/min/1.73m² (p < 0.001). Conclusion: The study revealed a high frequency of diabetic nephropathy in type 2 diabetes, linked to poor glycemic control, declining eGFR and complications.
References
de Farias MEB, de Lemos Araújo Queiroz DC, Victor FM. Diabetic Nephropathy. Endocrinol Diabetes A Probl Oriented Approach Second Ed [Internet]. 2022 Jan 9 [cited 2025 Feb 17]; 397-409. Available from: https://www.ncbi.nlm.nih.gov/books/NBK534200/. doi: 10.1007/978-3-030-90684-9_37. DOI: https://doi.org/10.1007/978-3-030-90684-9_37
Gnudi L. Renal disease in patients with type 2 diabetes: magnitude of the problem, risk factors and preventive strategies. La Presse Médicale. 2023 Mar; 52(1): 104159. doi: 10.1016/j.lpm.2022.104159. DOI: https://doi.org/10.1016/j.lpm.2022.104159
Thipsawat S. Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: A review of the literature. Diabetes and Vascular Disease Research. 2021 Nov; 18(6): 14791641211058856. doi: 10.1177/14791641211058856. DOI: https://doi.org/10.1177/14791641211058856
Wang N and Zhang C. Recent advances in the management of diabetic kidney disease: Slowing progression. International Journal of Molecular Sciences. 2024 Mar; 25(6): 3086. doi: 10.3390/ijms25063086. DOI: https://doi.org/10.3390/ijms25063086
Ali A, Khan A, Butt AR. Prevalence of Risk Factors of Diabetic Nephropathy and Their Association with Estimated GFR in Patients of Type 2 Diabetes Mellitus. Gomal Journal of Medical Sciences. 2023 Mar; 21(1): 31-6. doi: 10.46903/gjms/21.01.1296.
Abdelwahid HA, Dahlan HM, Mojemamy GM, Darraj GH. Predictors of microalbuminuria and its relationship with glycemic control among Type 2 diabetic patients of Jazan Armed Forces Hospital, southwestern Saudi Arabia. BioMed Central Endocrine Disorders. 2022 Dec; 22(1): 307. doi: 10.1186/s12902-022-01232-y. DOI: https://doi.org/10.1186/s12902-022-01232-y
Heo GY, Koh HB, Kim HW, Park JT, Yoo TH, Kang SW et al. Glycemic control and adverse clinical outcomes in patients with chronic kidney disease and type 2 diabetes mellitus: results from KNOW-CKD. Diabetes & Metabolism Journal. 2023 Apr; 47(4): 535-46. doi: 10.4093/dmj.2022.0112. DOI: https://doi.org/10.4093/dmj.2022.0112
Kung K, Chow KM, Hui EM, Leung M, Leung SY, Szeto CC et al. Retracted Article: Prevalence of complications among Chinese diabetic patients in urban primary care clinics: a cross-sectional study. BioMed Central Family Practice. 2014 Jan; 15(1): 8. doi: 10.1186/1471-2296-15-8. DOI: https://doi.org/10.1186/1471-2296-15-8
Sana MA, Chaudhry M, Malik A, Iqbal N, Zakiuddin A, Abdullah M. Prevalence of microalbuminuria in type 2 diabetes mellitus. Cureus. 2020 Dec; 12(12). doi: 10.7759/cureus.12318. DOI: https://doi.org/10.7759/cureus.12318
Ullah A, Kausar SA, Ayaz M, Khan MS, Ullah S, Saeed RF. Frequency of Diabetic Nephropathy in Type 2 Diabetic Patients Using Spot Urine ACR and Its Associated Risk Factors. Life and Science. 2024 Nov; 5(4): 06-. doi: 10.37185/LnS.1.1.805. DOI: https://doi.org/10.37185/LnS.1.1.805
Dias JP, Shardell M, Golden SH, Ahima RS, Crews DC. Racial/ethnic trends in prevalence of diabetic kidney disease in the United States. Kidney International Reports. 2019 Feb; 4(2): 334-7. doi: 10.1016/j.ekir.2018.10.018. DOI: https://doi.org/10.1016/j.ekir.2018.10.018
Ang YG, Heng BH, Saxena N, Liew ST, Chong PN. Annual all-cause mortality rate for patients with diabetic kidney disease in Singapore. Journal of Clinical & Translational Endocrinology. 2016 Jun; 4: 1-6. doi: 10.1016/j.jcte.2016.01.002. DOI: https://doi.org/10.1016/j.jcte.2016.01.002
Hannedouche T, Rossignol P, Darmon P, Halimi JM, Vuattoux P, Hagege A et al. Early diagnosis of chronic kidney disease in patients with diabetes in France: multidisciplinary expert opinion, prevention value and practical recommendations. Postgraduate Medicine. 2023 Oct; 135(7): 633-45. doi: 10.1080/00325481.2023.2256208. DOI: https://doi.org/10.1080/00325481.2023.2256208
Zahra S, Saleem MK, Ejaz KF, Akbar A, Jadoon SK, Hussain S et al. Prevalence of nephropathy among diabetic patients in North American region: a systematic review and meta-analysis. Medicine. 2024 Sep; 103(38): e39759. doi: 10.1097/MD.0000000000039759. DOI: https://doi.org/10.1097/MD.0000000000039759
Aryal S. HPLC: Principle, Parts, Types, Uses, Diagram. Microbe Notes [Internet]. 2023 [cited 2025 Apr 9]. Available from: https://microbenotes.com/high-performance-liquid-chromatography-hplc/. 2024 May.
Jelani I, Bunza JM, Abbas HK, Yale BM, Abacha FZ, Abdullahi HL. Comparison between Jaffe and enzymatic creatinine assays in renal dysfunction subjects. Saudi Journal of Medical and Pharmaceutical Sciences. 2021 May; 7(6): 267-9. doi: 10.36348/sjmps.2021.v07i06.007.
Wei R, Légaré W, McShane AJ. Autoverification-based algorithms to detect preanalytical errors: Two examples. Clinical Biochemistry. 2023 May; 115: 126-8. doi: 10.1016/j.clinbiochem.2022.06.010. DOI: https://doi.org/10.1016/j.clinbiochem.2022.06.010
Fu EL, Coresh J, Grams ME, Clase CM, Elinder CG, Paik J et al. Removing race from the CKD-EPI equation and its impact on prognosis in a predominantly White European population. Nephrology Dialysis Transplantation. 2023 Jan; 38(1): 119-28. doi: 10.1093/ndt/gfac197. DOI: https://doi.org/10.1093/ndt/gfac197
Jeerasuwannakul B, Sawunyavisuth B, Khamsai S, Sawanyawisuth K. Prevalence and risk factors of proteinuria in patients with type 2 diabetes mellitus. Asia-Pacific Journal of Science and Technology. 2021 Jan; 26(04): 1-5. doi: 10.14456/apst.2021.32.
Wan KS, Hairi NN, Mustapha F, Mohd Yusoff MF, Mat Rifin H, Ismail M et al. Prevalence of diabetic kidney disease and the associated factors among patients with type 2 diabetes in a multi-ethnic Asian country. Scientific Reports. 2024 Mar; 14(1): 7074. doi: 10.1038/s41598-024-57723-6. DOI: https://doi.org/10.1038/s41598-024-57723-6
Merid F, Getahun F, Esubalew H, Gezahegn T. Incidence and Predictors of Diabetic Nephropathy among Type 2 Diabetes Mellitus Patients, Southern Ethiopia. Journal of Nutrition and Metabolism. 2024 Jul; 2024(1): 6976870. doi: 10.1155/2024/6976870. DOI: https://doi.org/10.1155/2024/6976870
Farah RI, Al-Sabbagh MQ, Momani MS, Albtoosh A, Arabiat M, Abdulraheem AM et al. Diabetic kidney disease in patients with type 2 diabetes mellitus: a cross-sectional study. BioMed Central Nephrology. 2021 Jun; 22(1): 223. doi: 10.1186/s12882-021-02429-4. DOI: https://doi.org/10.1186/s12882-021-02429-4
Elhefnawy KA and Elsayed AM. Prevalence of diabetic kidney disease in patients with type 2 diabetes mellitus. The Egyptian Journal of Internal Medicine. 2019 Jun; 31: 149-54. doi: 10.4103/ejim.ejim_113_18. DOI: https://doi.org/10.4103/ejim.ejim_113_18
Aboelnasr MS, Shaltout AK, AlSheikh MR, Abdelhameed AH, Elrefaey W. Diabetic kidney disease in patients newly diagnosed with type-2 diabetes mellitus: incidence and associations. Saudi Journal of Kidney Diseases and Transplantation. 2020 Jan; 31(1): 191-9. doi: 10.4103/1319-2442.279940. DOI: https://doi.org/10.4103/1319-2442.279940
Hussain S, Jamali MC, Habib A, Hussain MS, Akhtar M, Najmi AK. Diabetic kidney disease: An overview of prevalence, risk factors, and biomarkers. Clinical Epidemiology and Global Health. 2021 Jan; 9: 2-6. doi: 10.1016/j.cegh.2020.05.016. DOI: https://doi.org/10.1016/j.cegh.2020.05.016
Kebede SA, Tusa BS, Weldesenbet AB, Tessema ZT, Ayele TA. Incidence of diabetic nephropathy and its predictors among type 2 diabetes mellitus patients at university of gondar comprehensive specialized hospital, Northwest Ethiopia. Journal of Nutrition and Metabolism. 2021 Aug; 2021(1): 6757916. doi: 10.1155/2021/6757916. DOI: https://doi.org/10.1155/2021/6757916
Fenta ET, Eshetu HB, Kebede N, Bogale EK, Zewdie A, Kassie TD et al. Prevalence and predictors of chronic kidney disease among type 2 diabetic patients worldwide, systematic review and meta-analysis. Diabetology & Metabolic Syndrome. 2023 Nov; 15(1): 245. doi: 10.1186/s13098-023-01202-x. DOI: https://doi.org/10.1186/s13098-023-01202-x
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Pakistan Journal of Health Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments
